The effect of experimental hyperglycemia and AT1 [angiotensin II type 1] [valsartan] receptor blockade on renal hemodynamics in impaired glucose tolerance

Trial Profile

The effect of experimental hyperglycemia and AT1 [angiotensin II type 1] [valsartan] receptor blockade on renal hemodynamics in impaired glucose tolerance

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Valsartan (Primary)
  • Indications Glucose intolerance
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top